The report aims at estimating the market size and future growth potential of Hormonal Contraceptive market across different segments such as type, application and geography. The base year considered for the study is 2023, and the market size is forecast from 2024 to 2030.
The global Hormonal Contraceptive market size in 2023 is 16600.0 million US dollars, and it is expected to be 22742.1 million US dollars by 2030, with a compound annual growth rate of 4.60% expected in 2024-2030.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Hormonal Contraceptive market include Abbvie, Inc (U.S.), Afaxys, Inc. (U.S.), Merck & Co Inc. (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), and Bayer AG (Germany). The share of the top 3 players in the Hormonal Contraceptive market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Hormonal Contraceptive market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Male accounted for XX% of Hormonal Contraceptive market in 2023. Female share of XX%.
Hospitals accounted for XX% of the Hormonal Contraceptive market in 2023. Homecare accounts for XX%.
The research methodology used to estimate and forecast the Hormonal Contraceptive market begins by capturing data on key market player revenues through secondary research. The bottom-up procedure has been employed to arrive at the overall market size, by considering the revenue of key players in the market. After arriving at the overall market size, the total market has been split into several segments and sub-segments, which has been verified through primary research by conducting extensive interviews with key people such as industry experts, executives. This data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for segments and sub-segments.
This report provides the integrated ecosystem of the Hormonal Contraceptive market which offers holistic view of current demand and vendor side market. The research study answers several significant questions, primarily which market segments to focus on in next two to five years to prioritize factors such as resource effort, and investment.
Key Target audience:
Hormonal Contraceptive Manufacturers and Suppliers
Research and Development (R&D) Companies
Business Research and Consulting Service Providers
Research Organizations
Academic Centers and Universities Associations and Industrial Bodies
Technology Investors
Chapter Outline
Chapter 1: Introduces the product overview, research purposes, and then includes economic analysis of global regions and inflation analysis,
Chapter 2: Analyzes the Hormonal Contraceptive manufacturing cost, including manufacturing cost structure, and industrial chain.
Chapter 3: Analysis of the competitive environment of Hormonal Contraceptive market participants. This mainly includes the revenue and market share of the top players, along with the players' M&A and expansion in recent years.
Chapter 4: Analyzes the main companies in the Hormonal Contraceptive industry, including their main businesses, products/services, revenue, gross and gross margin.
Chapters 5-7: Segmented the global Hormonal Contraceptive market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 8-12: Provide North America, EMEA, China, Asia-Pacific and Latin America Hormonal Contraceptive market type, application, country and player market segmentation revenue data.
Chapter 13: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapter 14: The main points and conclusions of the report.
Highlights-Regions
North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
EMEA
Europe
Germany
France
UK
Italy
Russia
Nordic
Middle East
Africa
Latin America
Brazil
Argentina
Mexico
Player list
Abbvie, Inc (U.S.)
Afaxys, Inc. (U.S.)
Merck & Co Inc. (U.S.)
Teva Pharmaceuticals Industries Ltd. (Israel)
Bayer AG (Germany)
Pfizer Inc. (U.S.)
Agile Therapeutics (U.S.)
Cupid Ltd. (India)
Helm AG (Germany)
Church & Dwight Co., Inc (U.S.)
Organon group of companies (U.S.)
Reckitt Benckiser Group PLC (U.K.)
Veru Inc. (U.S.)
Boehringer Ingelheim International GmbH (Germany)
Novartis AG (Switzerland)
Lupin (India)
Glenmark Pharmaceuticals (India)
Types list
Male
Female
Application list
Hospitals
Homecare
Clinics
Gynecology Centers
Ambulatory Surgical Centers (ASC)
